Cargando…
Recommendations for the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19()
As of April 6, 2020, there are over 1,200,000 reported cases and 70,000 deaths worldwide due to COVID-19, the disease caused by the SARS-CoV-2 virus, and these numbers rise exponentially by the day [1]. According to the Centers for Disease Control (CDC), the most effective means of minimizing the sp...
Autores principales: | Tchelebi, Leila T., Haustermans, Karin, Scorsetti, Marta, Hosni, Ali, Huguet, Florence, Hawkins, Maria A., Dawson, Laura A., Goodman, Karyn A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194719/ https://www.ncbi.nlm.nih.gov/pubmed/32342878 http://dx.doi.org/10.1016/j.radonc.2020.04.010 |
Ejemplares similares
-
Hepatocellular Carcinoma in the COVID‐19 Era: Primetime for Stereotactic Body Radiotherapy and a Lesson for the Future?
por: Scorsetti, Marta, et al.
Publicado: (2020) -
Response to, “Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond”()
por: Tchelebi, Leila T., et al.
Publicado: (2021) -
Stereotactic Body Radiation Therapy in the Management of Upper GI Malignancies
por: Tchelebi, Leila, et al.
Publicado: (2018) -
Radiation therapy for pancreatic adenocarcinoma, a treatment option that must be considered in the management of a devastating malignancy
por: Hall, William A., et al.
Publicado: (2019) -
External beam radiation therapy for locally advanced and metastatic gastrointestinal stromal tumors
por: Cuaron, John J, et al.
Publicado: (2013)